At least 30 new jobs in biosafety testing are expected at the Stirling premises of a life sciences giant.
Merck today (Wed) will announce a £35m investment covering its Glasgow (Todd Campus, Altum Building) and Stirling University Innovation Park sites.
The new funding will create 500 new jobs across both sites, creating a combined workforce of over 1,200 employees across Glasgow and Stirling.
A Merck spokesperson said that “30-plus” jobs are expected in Stirling to add to an existing workforce of 99.
The Stirling facility first opened in 1990 under the name of Microbiological Associates.
Biosafety testing is a critical step in the drug development and manufacturing process that ensures drugs are safe, effective, and meet regulatory requirements.
Merck Scottish sites head and managing director David McClelland said: “Merck has a wealth of testing expertise spanning over 75 years, including 33 years here in Scotland.
Click here for more news and sport from the Stirling area.
“The biosafety testing services at our sites in Glasgow and Stirling have been experiencing strong, double-digit growth for several years.
“This investment is a significant announcement for Merck in Scotland and an acknowledgment of the great work of our on-site teams.”
CEO of the Scottish Life Sciences Association, Stuart Armstrong, added: “This is great news for Scottish Life Sciences and Scotland as a whole. We are delighted to continue to support Merck as they expand again in Glasgow and Stirling.
“We will work alongside Merck to ensure they have all the resources they need to deliver a successful project.
“Making sure we have the skilled people to fill these jobs is a priority for us and it is excellent to be working with Glasgow Caledonian University, Stirling University and Forth Valley College, amongst others, to ensure we have students graduating with more than just an appreciation of the world class regulatory environment they’ll be working in.”
